These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12688335)

  • 1. Late and long-lasting response in an adult chronic idiopathic thrombocytopenic purpura after extended course of rituximab.
    D'Arena G; Luigiavigliotti M; Coccaro M; Iodice G; Tartarone A; Matera R; Di Renzo N
    Leuk Lymphoma; 2003 Mar; 44(3):561-2. PubMed ID: 12688335
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura and splenic marginal-zone B-cell lymphoma: a casual correlation?
    Magagnoli M; Balzarotti M; Castagna L; Rahal D; Siracusano L; Nozza A; Santoro A
    Leuk Lymphoma; 2003 Sep; 44(9):1639-40. PubMed ID: 14565674
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of vincristine in refractory auto-immune thrombocytopenic purpura.
    Van Zyl-Smit R; Jacobs P
    S Afr Med J; 1974 Oct; 48(48):2039-41. PubMed ID: 4474709
    [No Abstract]   [Full Text] [Related]  

  • 5. Danazol in refractory autoimmune thrombocytopenic purpura (ATP). A new therapeutic sequence.
    Ambriz-Fernández R; Chávez-Sánchez G; Pizzuto-Chávez J; Morales-Polanco MR; Aviles-Miranda A
    Arch Invest Med (Mex); 1985; 16(3):295-304. PubMed ID: 3833096
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
    Cooper N; Stasi R; Cunningham-Rundles S; Feuerstein MA; Leonard JP; Amadori S; Bussel JB
    Br J Haematol; 2004 Apr; 125(2):232-9. PubMed ID: 15059147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab for chronic immune thrombocytopenic purpura.
    Bay A; Oner AF
    J Pediatr; 2006 Mar; 148(3):423-4; author reply 424. PubMed ID: 16615987
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D
    Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia.
    Faurschou M; Hasselbalch HC; Nielsen OJ
    Eur J Haematol; 2001 Jun; 66(6):408-11. PubMed ID: 11488941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
    Delgado J; Bustos JG; Jimenez-Yuste V; Hernandez-Navarro F
    Haematologica; 2002 Feb; 87(2):215-6. PubMed ID: 11836172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term clinical course of patients with chronic autoimmune thrombocytopenic purpura].
    Muñiz-Ugarte JG; Dorantes-Mesa S; Mejía-Domínguez AM
    Bol Med Hosp Infant Mex; 1989 Jul; 46(7):477-81. PubMed ID: 2765161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic idiopathic thrombocytopenic purpura. Treatment with steroids and splenectomy.
    JiJi RM; Firozvi T; Spurling CL
    Arch Intern Med; 1973 Sep; 132(3):380-3. PubMed ID: 4798764
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune thrombocytopenic purpura.
    Karpatkin S
    Am J Med Sci; 1971 Mar; 261(3):127-38. PubMed ID: 4933874
    [No Abstract]   [Full Text] [Related]  

  • 14. Fresh frozen plasma in the treatment of chronic autoimmune thrombocytopenic purpura in adults: evidence for potentiating effect of vincristine.
    Bharucha C; Magennis H
    Clin Lab Haematol; 1985; 7(2):119-24. PubMed ID: 4042564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune thrombocytopenic purpura: pathophysiology and treatment].
    Godeau B
    Transfus Clin Biol; 2009 May; 16(2):101-5. PubMed ID: 19409827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
    Moschovi M; Trimis G; Pergantou H; Platokouki H; Vrachnou E; Tzortzatou-Stathopoulou F
    J Paediatr Child Health; 2005 Jul; 41(7):384-6. PubMed ID: 16014149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A; Catlett JP
    South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights.
    Silverman GJ
    Front Biosci; 2007 Jan; 12():2194-206. PubMed ID: 17127456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between response to corticosteroids and splenectomy for adult idiopathic thrombocytopenic purpura.
    Brennan MF; Rappeport JM; Moloney WC; Wilson RE
    Am J Surg; 1975 Apr; 129(4):490-2. PubMed ID: 1092196
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.